山东出台《关于全面深化药品医疗器械监管改革促进医药产业高质量发展的实施意见》

Core Viewpoint - The Shandong provincial government has issued a policy document aimed at enhancing drug and medical device regulation to promote high-quality development in the pharmaceutical industry, marking a significant step in reforming drug regulation and advancing the industry in the province [3]. Group 1: Policy Overview - The document titled "Implementation Opinions on Deepening Drug and Medical Device Regulation Reform to Promote High-Quality Development of the Pharmaceutical Industry" outlines 29 measures across six key areas [4]. - The initiative emphasizes the importance of drug and medical devices as critical goods for public health and economic development, reflecting the central government's commitment to drug safety [3]. Group 2: Key Measures - Strengthening the cultivation of pharmaceutical innovation by supporting cutting-edge technology, enhancing innovation platform construction, and promoting the transformation of innovative drugs and devices [4]. - Optimizing the clinical trial ecosystem by encouraging medical institutions to undertake trials, improving ethical review efficiency, and applying AI technology [4]. - Deepening review and approval reforms by aligning with national drug regulatory frameworks and enhancing the service system for drug production and innovation [4]. - Promoting the clinical use of innovative products by establishing a catalog of innovative products and improving the medical insurance payment mechanism [4]. - Encouraging international development of the industry through targeted investment attraction and enhancing international cooperation [4]. - Strengthening quality supervision throughout the process by enforcing corporate responsibility and enhancing smart regulatory capabilities [4].